Search Login Register

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Summary

1756 relevant articles (55 outcomes, 229 trials/studies) found for this Bio-Agent

Description: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.

Also Known As: MPTP; N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-

Key Diseases for which 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine is Relevant

  1. Parkinson Disease (Parkinson's Disease) : 26 outcomes 117 studies in 815 results
  2. Parkinsonian Disorders (Parkinsonism) : 9 outcomes 49 studies in 549 results
  3. Dyskinesias (Dyskinesia) : 6 outcomes 27 studies in 141 results
  4. Tremor (Tremors) : 3 outcomes 1 study in 60 results
  5. Reperfusion Injury : 2 outcomes 4 studies in 26 results
Show All >>

Drugs Related to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

  1. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
  2. Dopamine (Intropin)
  3. Levodopa (L Dopa)
  4. Selegiline (E250)
  5. Neurotoxins
  6. Monoamine Oxidase (MAO)
  7. Haloperidol (Haldol)
  8. Reserpine (Serpasil)
  9. Adenosine
  10. SK&F 82958 (SKF 82958)
Show All >>

Therapies Related to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

  1. Transplantation (Transplant Recipients)
  2. Aftercare (After-Treatment)
  3. Denervation
  4. Transplants (Transplant)
  5. Lasers (Laser)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.